Christopher E Buller - JoVE Visualize

Showing results (41-50 of 86) with videos related to

Pageof 9

Sort By:

Circulation|October 20, 2004

Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or interventionKonstantinos Spargias, Elias Alexopoulos, Stamatis Kyrzopoulos, et al.

American Heart Journal|June 20, 2012

Long-term outcomes after a strategy of percutaneous coronary intervention of the infarct-related artery with drug-eluting stents or bare metal stents vs medical therapy alone in the Occluded Artery Trial (OAT)Xavier Freixa, Vladimír Džavík, Sandra A Forman, et al.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 25, 2005

Effect of bare metal stenting on angiographic and clinical outcomes in diabetic and nondiabetic patients undergoing percutaneous coronary intervention of nonacute occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA)Kok-Meng Yee, Christopher E Buller, Diane Catellier, et al.

European Heart Journal|June 12, 2004

Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stentingAmit Segev, Saleem Kassam, Christopher E Buller, et al.

American Heart Journal|November 5, 2003

Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trialJohn K French, Henry A Feldman, Susan F Assmann, et al.

The American Journal of Cardiology|January 28, 2010

Impact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT])Mariusz Kruk, Christopher E Buller, James Enlou Tcheng, et al.

Journal of the American College of Cardiology|May 4, 2004

The profile of cardiac patients with renal artery stenosisChristopher E Buller, Jorge G Nogareda, Krishnan Ramanathan, et al.

Heart (British Cardiac Society)|January 23, 2014

Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trialJuan J Russo, Shaun G Goodman, Warren J Cantor, et al.

European Heart Journal|July 5, 2011

Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudyThomas J Povsic, William A Wargin, John H Alexander, et al.

Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 3, 2012

Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) studyMadhu K Natarajan, Bradley H Strauss, Michael Rokoss, et al.

Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:

Pageof 9

Circulation|October 20, 2004

Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or interventionKonstantinos Spargias, Elias Alexopoulos, Stamatis Kyrzopoulos, et al.

American Heart Journal|June 20, 2012

Long-term outcomes after a strategy of percutaneous coronary intervention of the infarct-related artery with drug-eluting stents or bare metal stents vs medical therapy alone in the Occluded Artery Trial (OAT)Xavier Freixa, Vladimír Džavík, Sandra A Forman, et al.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 25, 2005

Effect of bare metal stenting on angiographic and clinical outcomes in diabetic and nondiabetic patients undergoing percutaneous coronary intervention of nonacute occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA)Kok-Meng Yee, Christopher E Buller, Diane Catellier, et al.

European Heart Journal|June 12, 2004

Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stentingAmit Segev, Saleem Kassam, Christopher E Buller, et al.

American Heart Journal|November 5, 2003

Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trialJohn K French, Henry A Feldman, Susan F Assmann, et al.

The American Journal of Cardiology|January 28, 2010

Impact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT])Mariusz Kruk, Christopher E Buller, James Enlou Tcheng, et al.

Journal of the American College of Cardiology|May 4, 2004

The profile of cardiac patients with renal artery stenosisChristopher E Buller, Jorge G Nogareda, Krishnan Ramanathan, et al.

Heart (British Cardiac Society)|January 23, 2014

Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trialJuan J Russo, Shaun G Goodman, Warren J Cantor, et al.

European Heart Journal|July 5, 2011

Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudyThomas J Povsic, William A Wargin, John H Alexander, et al.

Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 3, 2012

Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) studyMadhu K Natarajan, Bradley H Strauss, Michael Rokoss, et al.

Pageof 9